Abstract

Historically, the use of antibiotics was not well regulated in veterinary medicine. The emergence of antibiotic resistance (ABR) in pathogenic bacteria in human and veterinary medicine has driven the need for greater antibiotic stewardship. The preservation of certain antibiotic classes for use exclusively in humans, especially in cases of multidrug resistance, has highlighted the need for veterinarians to reduce its use and redefine dosage regimens of antibiotics to ensure efficacy and guard against the development of ABR pathogens. The minimum inhibitory concentration (MIC), the lowest concentration of an antibiotic drug that will prevent the growth of a bacterium, is recognised as a method to assist in antibiotic dosage determination. Minimum inhibitory concentrations sometimes fail to deal with first-step mutants in bacterial populations; therefore dosing regimens based solely on MIC can lead to the development of ABR. The mutant prevention concentration (MPC) is the minimum inhibitory antibiotic concentration of the most resistant first-step mutant. Mutant prevention concentration determination as a complementary and sometimes preferable alternative to MIC determination for veterinarians when managing bacterial pathogens. The results of this study focused on livestock pathogens and antibiotics used to treat them, which had a MIC value of 0.25 µg/mL for enrofloxacin against all 27 isolates of Salmonella typhimurium. The MPC values were 0.50 µg/mL, with the exception of five isolates that had MPC values of 4.00 µg/mL. The MPC test yielded 65.52% (18 isolates) Salmonella isolates with florfenicol MICs in the sensitive range, while 11 isolates were in the resistant range. Seventeen isolates (58.62%) of Pasteurella multocida had MIC values in the susceptible range and 41.38% (12 isolates) had an intermediate MIC value. Mutant prevention concentration determinations as done in this study is effective for the antibiotic treatment of bacterial infections and minimising the development of resistance. The MPC method can be used to better control to prevent the development of antibiotic drug resistance used in animals.

Highlights

  • The growing problem of antibiotic resistance (ABR) is of global concern, with many multidrug resistant bacteria listed in human medicine

  • Isolates of Salmonella typhimurium and Pasteurella multocida from specimens obtained from the Department of Veterinary Tropical Diseases, University of Pretoria, Idexx Laboratories, Disease Control Africa, Stellenbosch Provincial Veterinary Laboratory, Pathcare Veterinary Laboratories and Vetdiagnostix were all confirmed and bio-banked on beads (Cryobank®, Thermo Fischer) at –70 oC until it could be processed for minimum inhibitory concentration (MIC) and mutant prevention concentration (MPC) tests (Wentzel 2013)

  • Seventeen (58.62%) isolates of P. multocida had susceptible MIC values and 12 (41.38%) isolates had an intermediate value, while 16 (55.17%) of the isolates yielded a resistant MPC value to oxytetracycline while five isolates had an MIC/MPC ratio of 0 (Wentzel 2013)

Read more

Summary

Introduction

The growing problem of antibiotic resistance (ABR) is of global concern, with many multidrug resistant bacteria listed in human medicine. This issue is becoming increasingly relevant in veterinary medicine with the risk of resistance genes being transferred between pathogens of humans and animals through various routes and the increasing limitations on antibiotic use in animals, especially food-producing animals. Research has shown that the mutant prevention concentration (MPC) addresses the limitations of MICs in situations such as persistent bacterial infections, where standard dosing is ineffective.

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call